Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 58 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
WERBROUCK B MD from Ieper, company number BE0633893119, closed financial year 2025 with a result of € 315,556 after tax. For that financial year WERBROUCK B MD recorded a gross margin of € 420,747 and equity of € 226,986. Compared with financial year 2024, the result moved from € 311,381 to € 315,556. Profitable, and profit is growing. The buffer shrank hard: equity is 67 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.
€ 226,986
▼ 67% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 315,556
▲ 1% vs 2024
Profit after tax over the fiscal year.
€ 72,762
▲ 174% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 769,290 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 10,968
▲ 181% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 644
▼ 17% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 29,762
▲ 138% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 370,411 | € 381,331 | € 424,752 | € 420,747 | ▼ 1% |
| Profit after taxes | € 260,445 | € 278,156 | € 311,381 | € 315,556 | ▲ 1% |
| Equity | € 521,228 | € 594,339 | € 680,720 | € 226,986 | ▼ 67% |
| Total debts | € 96,425 | € 101,879 | € 218,109 | € 627,974 | ▲ 188% |
| Cash | € 281,519 | € 68,720 | € 26,584 | € 72,762 | ▲ 174% |
| Land & buildings | € 1,700 | € 1,417 | € 1,133 | € 850 | ▼ 25% |
| Retained profit | € 502,628 | € 575,739 | € 662,120 | € 208,386 | ▼ 69% |
| Dividend | € 437,000 | € 205,045 | € 225,000 | € 769,290 | ▲ 242% |
| Balance sheet total | € 617,653 | € 696,219 | € 898,829 | € 854,960 | ▼ 5% |
Key figures of WERBROUCK B MD, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to WERBROUCK B MD?
What happened at WERBROUCK B MD in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 315,556 (▲ 1% vs 2024). filed late Source: NBB ↗
- New establishment in Ieper. KBO
- Start of the company according to the CBE. KBO
In short
From € 260,445 profit in 2022 to € 315,556 profit in 2025.
Paid € 372,945 in corporate taxes since 2022.
Best year ever: 2025, with € 315,556 profit.
Paid out € 1.6 million in dividends to the owners in total.
Management
Behind WERBROUCK B MD is Bart Werbrouck.
Directors
According to the 2025 annual accounts
Bart Werbrouck
Director
Establishments
Establishment units
Physical locations of this company
Pilkemseweg 31
8900 Ieper
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0633.893.119
- VAT number
- BE 0633.893.119
- Registered office
- Pilkemseweg 31, 8900 Ieper
- Names & denominations
- WERBROUCK B MD
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 July 2015
- Peppol
- Active · Active since 15 Dec 2025
- Activities · NACE
Activiteiten van medisch specialisten
Activiteiten op het gebied van voeding
Overige menselijke gezondheidszorg, n.e.g.